Overview

Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
To explore the antiviral effect of nucleoside analogue in late pregnancy and the safety of the antiviral drug to fetus.To establish the best therapy strategy to pregnant women with high level of HBV DNA.
Phase:
Phase 4
Details
Lead Sponsor:
Hua Zhang
Collaborator:
Icahn School of Medicine at Mount Sinai
Treatments:
Lamivudine
Telbivudine